IMPACT OF PRIOR TUMOUR NECROSIS FACTOR INHIBITOR FAILURE AND PRIOR CORTICOSTEROID USE ON THE MAINTENANCE OF EFFICACY OF TOFACITINIB FOLLOWING DOSE REDUCTION IN PATIENTS WITH ULCERATIVE COLITIS WHO WERE IN STABLE REMISSION: 6-MONTH DATA FROM THE DOUBLE-BLIND, RANDOMISED RIVETING STUDY

Marla C. Dubinsky  1     William J. Sandborn  2     Sean Gardiner  3     Rajiv Mundayat  3     Irene Modesto  3     Jerome Paulissen  3     Severine Vermeire  4     Paulo Kotze  5     Chinyu Su     Nervin Lawendy     nicole kulisek     Geert D’Haens     Joana Torres    
1 Icahn School of Medicine at Mount Sinai,New York,United States
2 University of California,La Jolla,United States
3 Pfizer Inc,New York, NY,United States
4 University Hospitals Leuven,Leuven,Belgium
5 Catholic University o

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing